株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオマテリアルの世界市場 - 2021年までの予測:材料タイプ別 (金属、セラミック、ポリマー、天然)、用途別 (心血管、整形外科、歯科、美容整形、創傷治療、神経、組織エンジニアリング、眼科)

Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 265105
出版日 ページ情報 英文 264 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.93円で換算しております。
Back to Top
バイオマテリアルの世界市場 - 2021年までの予測:材料タイプ別 (金属、セラミック、ポリマー、天然)、用途別 (心血管、整形外科、歯科、美容整形、創傷治療、神経、組織エンジニアリング、眼科) Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2021
出版日: 2017年01月04日 ページ情報: 英文 264 Pages
概要

世界のバイオマテリアル市場は2016〜2021年にかけCAGR16.0%で拡大し、2016年の709億米ドルから2021年までに1,491億7,000万米ドルに達すると予測されています。各国政府の助成や資金援助、心血管疾患の発症率上昇、技術的発展、埋込型装置市場の拡大、股関節・膝関節置換術件数の増加、組織エンジニアリングの認知度向上などが市場の成長を牽引しています。

当レポートでは、世界のバイオマテリアル市場について調査し、市場の動向、材料タイプ別、用途別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 課題

第6章 法規制評価

  • イントロダクション
  • 米国
  • 欧州
  • 日本
  • 中国
  • インド
  • オーストラリア

第7章 材料タイプ別市場

  • イントロダクション
  • 金属
  • セラミック
  • ポリマー
  • 天然

第8章 用途別市場

  • イントロダクション
  • 心血管
  • 整形外科
  • 眼科
  • 歯科
  • 美容整形
  • 創傷治療
  • 組織エンジニアリング/神経/中枢神経系
  • その他

第9章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第10章 競合環境

  • 概要
  • 主要企業の比較評価
  • 競合シナリオ
  • 協定、連携、提携、合弁
    • 製品上市
    • 合併・買収
    • 拡充
    • その他の戦略

第11章 企業プロファイル

  • イントロダクション
  • ROYAL DSM
  • BASF SE
  • CORBION N.V.
  • COVESTRO (SUBSIDIARY OF BAYER AG)
  • INVIBIO LTD. (SUBSIDIARY OF VICTREX PLC)
  • CARPENTER TECHNOLOGY CORPORATION
  • EVONIK INDUSTRIES AG
  • BERKELEY ADVANCED BIOMATERAILS, INC.
  • CAM BIOCERAMICS BV
  • CELANESE CORPORATION

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 1556

The biomaterials market is projected to reach 149.17 billion by 2021 million from 70.90 billion in 2016, at a CAGR of 16.0%.

Factors such as increasing funds and grants by governments worldwide, rising incidence of cardiovascular diseases, technological advancements, the growing implantable devices market, globally rising cases of hip and knee replacement procedures, rising awareness of tissue engineering, and high growth in geriatric population are driving the growth of the market. On the other hand, stringent clinical and regulatory processes and unfavorable healthcare reforms in the U.S., is expected to restrain the growth of the market.

The demand for biodegradable polymers has increased, owing to its superior biocompatibility and ability to slowly degrade inside the body, thus eliminating the need for removal. Superior physicochemical & biocompatible properties and the increasing application areas of polymeric materials are likely to boost the growth of the market. However, polymers are costly, which can hinder the growth of this market. A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems.

The plastic surgery segment is expected to grow at the highest CAGR during forecast period, due to growing number of elderly people, positive public perception towards cosmetic surgeries, and technological advances are factors increasing the demand for plastic surgeries. In 2016, the cardiovascular segment is expected to account for the largest share of the market, due to factors such as increasing prevalence of cardiovascular diseases, increasing angiography procedures, and growing usage of cardiac stents that are considered a safe option for coronary angioplasty treatment.

In 2016, North America is expected to account for the largest share of the global biomaterial market, followed by Europe, Asia-Pacific, and RoW. Rising biomaterial-based research, increasing demand for plastic surgeries, increasing conferences on biomaterials, growing cancer incidence, and the rising prevalence of cardiovascular diseases are expected to drive market growth in this region. In the coming years, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as increasing Japan's growing healthcare industry, increasing aging population, and high incidence of cardiovascular diseases in India and China.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global biomaterials market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the biomaterials market.

  • By Company Type: Tier 1: 34%, Tier 2: 38%, Tier 3: 28%
  • By Designation: Director-level: 31%, C-level: 35%, Others: 34%
  • By Region: North America: 28%, Europe: 31%, APAC: 24%, RoW: 17%

The report includes the study of key players.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the biomaterials market. The report analyzes the biomaterials market, by type of material and application
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the biomaterials market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various biomaterials across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the biomaterials market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the biomaterials market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. MARKETS COVERED
    • 1.2.2. YEARS CONSIDERED FOR THE STUDY
  • 1.3. CURRENCY
  • 1.4. LIMITATIONS
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL BIOMATERIALS MARKET OVERVIEW
  • 4.2. GLOBAL BIOMATERIALS MARKET, BY APPLICATION
  • 4.3. GEOGRAPHIC ANALYSIS: BIOMATERIALS MARKET, BY TYPE
  • 4.4. GEOGRAPHIC SNAPSHOT: BIOMATERIALS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increased funds and grants by government bodies for the development of novel biomaterials
      • 5.2.1.2. Increasing demand for implantable devices
      • 5.2.1.3. Growing demand for biomaterials in plastic surgery and wound healing applications
      • 5.2.1.4. Rising number of hip and knee replacement procedures
      • 5.2.1.5. Rising geriatric population and the subsequent growth in incidence of cardiovascular diseases
      • 5.2.1.6. Increasing awareness about regenerative medicine
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Stringent clinical & regulatory processes
      • 5.2.2.2. Unfavorable healthcare reforms in the U.S.
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing healthcare market in emerging economies
      • 5.2.3.2. Increasing number of free-trade agreements
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Limitations of biomaterial-based products

6. REGULATORY ASSESSMENT

  • 6.1. INTRODUCTION
  • 6.2. U.S.
    • 6.2.1. INTRODUCTION
    • 6.2.2. FDA DEVICE CLASSIFICATION
    • 6.2.3. U.S.: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.2.4. STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS
  • 6.3. EUROPE
    • 6.3.1. INTRODUCTION
    • 6.3.2. EUROPEAN MEDICAL DEVICE CLASSIFICATION
    • 6.3.3. EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.3.4. EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE
  • 6.4. JAPAN
    • 6.4.1. INTRODUCTION
    • 6.4.2. PMDA DEVICE CLASSIFICATION
    • 6.4.3. JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.4.4. REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN
  • 6.5. CHINA
    • 6.5.1. INTRODUCTION
    • 6.5.2. CFDA DEVICE CLASSIFICATION
    • 6.5.3. CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT
    • 6.5.4. RISING HURDLES IN THE REGULATORY PROCESS IN CHINA
  • 6.6. INDIA
    • 6.6.1. INTRODUCTION
    • 6.6.2. INDIA: REGULATORY APPROVAL TIMELINE ASSESSMENT
  • 6.7. AUSTRALIA
    • 6.7.1. INTRODUCTION
    • 6.7.2. TGA DEVICE CLASSIFICATION
    • 6.7.3. AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT

7. GLOBAL BIOMATERIALS MARKET, BY TYPE OF MATERIAL

  • 7.1. INTRODUCTION
  • 7.2. METALLIC BIOMATERIALS
    • 7.2.1. STAINLESS STEEL
    • 7.2.2. TITANIUM & TITANIUM ALLOYS
    • 7.2.3. COBALT-CHROME ALLOYS
    • 7.2.4. GOLD
    • 7.2.5. SILVER
    • 7.2.6. MAGNESIUM
  • 7.3. CERAMICS
    • 7.3.1. CALCIUM PHOSPHATE
    • 7.3.2. ZIRCONIA
    • 7.3.3. ALUMINUM OXIDE
    • 7.3.4. CALCIUM SULFATE
    • 7.3.5. CARBON
    • 7.3.6. GLASS
  • 7.4. POLYMERS
    • 7.4.1. POLYMETHYLMETHACRYLATE (PMMA)
    • 7.4.2. POLYETHYLENE
    • 7.4.3. POLYESTER
    • 7.4.4. POLYVINYLCHLORIDE (PVC)
    • 7.4.5. SILICONE RUBBER
    • 7.4.6. NYLON
    • 7.4.7. POLYETHERETHERKETONE (PEEK)
    • 7.4.8. POLYLACTIC ACID, POLY GLYCOLIC ACID, AND POLY(LACTIDE-CO-GLYCOLIDE)
    • 7.4.9. OTHER POLYMERS
  • 7.5. NATURAL BIOMATERIALS
    • 7.5.1. HYALURONIC ACID
    • 7.5.2. COLLAGEN
    • 7.5.3. GELATIN
    • 7.5.4. FIBRIN
    • 7.5.5. CELLULOSE
    • 7.5.6. CHITIN
    • 7.5.7. ALGINATES
    • 7.5.8. SILK

8. BIOMATERIALS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. CARDIOVASCULAR
    • 8.2.1. CATHETERS
    • 8.2.2. STENTS
    • 8.2.3. IMPLANTABLE CARDIAC DEFIBRILLATORS
    • 8.2.4. PACEMAKERS
    • 8.2.5. SENSORS
    • 8.2.6. HEART VALVES
    • 8.2.7. VASCULAR GRAFTS
    • 8.2.8. GUIDEWIRES
    • 8.2.9. OTHERS
  • 8.3. ORTHOPEDIC
    • 8.3.1. JOINT REPLACEMENT
      • 8.3.1.1. Knee Replacement
      • 8.3.1.2. Hip Replacement
      • 8.3.1.3. Shoulder Replacement
      • 8.3.1.4. Others
    • 8.3.2. VISCOSUPPLEMENTATION
    • 8.3.3. BIORESORBABLE TISSUE FIXATION
      • 8.3.3.1. Suture Anchors
      • 8.3.3.2. Interference Screws
      • 8.3.3.3. Meniscal Repair Tacks
      • 8.3.3.4. Meshes
    • 8.3.4. SPINE
      • 8.3.4.1. Spinal Fusion
      • 8.3.4.2. Minimally Invasive Fusion Surgeries
      • 8.3.4.3. Motion Preservation & Dynamic Stabilization
        • 8.3.4.3.1. Pedicle-based Rod Systems
        • 8.3.4.3.2. Interspinous Spacers
        • 8.3.4.3.3. Disc Arthroplasty/Replacement
    • 8.3.5. FRACTURE FIXATION
      • 8.3.5.1. Bone Plates
      • 8.3.5.2. Screws
      • 8.3.5.3. Pins
      • 8.3.5.4. Rods
      • 8.3.5.5. Wires
    • 8.3.6. ORTHOBIOLOGICS
      • 8.3.6.1. Synthetics Bone Grafts
  • 8.4. OPHTHALMOLOGY
    • 8.4.1. CONTACT LENSES
    • 8.4.2. INTRAOCULAR LENSES
    • 8.4.3. FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
    • 8.4.4. SYNTHETIC CORNEAS
    • 8.4.5. OTHERS
  • 8.5. DENTAL
    • 8.5.1. DENTAL IMPLANTS
    • 8.5.2. DENTAL BONE GRAFTS & SUBSTITUTES
    • 8.5.3. DENTAL MEMBRANES
    • 8.5.4. TISSUE REGENERATION
  • 8.6. PLASTIC SURGERY
    • 8.6.1. SOFT TISSUE FILLERS
    • 8.6.2. CRANIOFACIAL SURGERY
  • 8.7. WOUND HEALING
    • 8.7.1. WOUND CLOSURE DEVICES
      • 8.7.1.1. Sutures
      • 8.7.1.2. Staples
    • 8.7.2. SURGICAL HEMOSTATS
    • 8.7.3. INTERNAL TISSUE SEALANTS
    • 8.7.4. ADHESION BARRIERS
    • 8.7.5. HERNIA MESHES
  • 8.8. TISSUE ENGINEERING
    • 8.8.1. SCAFFOLDS FOR REGENERATIVE MEDICINE
    • 8.8.2. NANOMATERIALS FOR BIOSENSING
    • 8.8.3. TAILORING OF INORGANIC NANOPARTICLES
  • 8.9. NEUROLOGICAL/CENTRAL NERVOUS SYSTEM
    • 8.9.1. SHUNTING SYSTEMS
    • 8.9.2. CORTICAL NEURAL PROSTHETICS (CNP)
    • 8.9.3. HYDROGEL SCAFFOLDS FOR CNS REPAIR
    • 8.9.4. NEURAL STEM CELL ENCAPSULATION
  • 8.10. OTHER APPLICATIONS
    • 8.10.1. DRUG DELIVERY SYSTEMS
    • 8.10.2. GASTROINTESTINAL APPLICATIONS
    • 8.10.3. BARIATRIC SURGERY
    • 8.10.4. URINARY APPLICATIONS

9. GLOBAL BIOMATERIALS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Biomaterials-based Research in the U.S.
      • 9.2.1.2. Growing Demand for Plastic Surgeries in the U.S.
      • 9.2.1.3. Conferences and Symposiums on Biomaterials in the U.S.
      • 9.2.1.4. Increase in Cancer Incidence
      • 9.2.1.5. Growing Prevalence of Cardiovascular Diseases
    • 9.2.2. CANADA
      • 9.2.2.1. Increasing R&D Activities for Biomaterials in Canada
      • 9.2.2.2. Growth in Geriatric Population in Canada
  • 9.3. EUROPE
    • 9.3.1. GERMANY
      • 9.3.1.1. Rising Cases of Hip and Knee Replacements
      • 9.3.1.2. Growing Medical Devices Industry in Germany
    • 9.3.2. U.K.
      • 9.3.2.1. Availability of Funds and Grants
      • 9.3.2.2. Rise in CVD Prevalence in the U.K.
      • 9.3.2.3. Conferences & Annual Meetings
      • 9.3.2.4. Rising Volume of Cosmetic Surgeries in the U.K.
    • 9.3.3. FRANCE
      • 9.3.3.1. Favorable Government Support, Growth in Aging Population
    • 9.3.4. SPAIN
      • 9.3.4.1. Increasing Research Activities on Biomaterials
    • 9.3.5. REST OF EUROPE (ROE)
      • 9.3.5.1. Improving Healthcare Structure in Russia
      • 9.3.5.2. RoE: Rising Geriatric Population
      • 9.3.5.3. Turkey: Growth in the Healthcare Sector, Rising Medical Tourism
  • 9.4. ASIA-PACIFIC
    • 9.4.1. INTERNATIONAL ALLIANCES
    • 9.4.2. JAPAN
      • 9.4.2.1. Japan's Growing Healthcare Industry
    • 9.4.3. CHINA
      • 9.4.3.1. Lucrative medical devices industry in China
      • 9.4.3.2. China's Favorable Tax Policy
      • 9.4.3.3. Growing Aging Population
    • 9.4.4. INDIA
      • 9.4.4.1. India: A Hotspot for Cosmetic and Plastic Surgery
      • 9.4.4.2. High Incidence of Cardiovascular Diseases
      • 9.4.4.3. Increasing Geriatric Population
    • 9.4.5. REST OF ASIA-PACIFIC (ROAPAC)
      • 9.4.5.1. Rising Volume of Hip and Knee Replacement Procedures in Australia
      • 9.4.5.2. Indonesia: Regulations Hindering Market Growth
      • 9.4.5.3. Increasing Research in Australia, Singapore, and Hong Kong
  • 9.5. REST OF THE WORLD (ROW)
      • 9.5.1.1. Middle East: Increasing Geriatric Population, Rise in Age-related Disorders
      • 9.5.1.2. High Prevalence of Obesity in Latin America
      • 9.5.1.3. Opportunities in the Brazilian Market
      • 9.5.1.4. Increasing Aging Population, Growing Cardiovascular Disease Prevalence in Brazil
      • 9.5.1.5. Market Scenario in Latin America and South Africa

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE BIOMATERIALS MARKET (2013-2016)
  • 10.3. COMPETITIVE SCENARIO
  • 10.4. AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND JOINT VENTURES
    • 10.4.1. PRODUCT LAUNCHES
    • 10.4.2. MERGERS AND ACQUISITIONS
    • 10.4.3. EXPANSIONS
    • 10.4.4. OTHER STRATEGIES

11. COMPANY PROFILES (Overview, Financial*, Products & Services, Strategy, and Developments)

  • 11.1. INTRODUCTION
  • 11.2. ROYAL DSM
  • 11.3. BASF SE
  • 11.4. CORBION N.V.
  • 11.5. COVESTRO (SUBSIDIARY OF BAYER AG)
  • 11.6. INVIBIO LTD. (SUBSIDIARY OF VICTREX PLC)
  • 11.7. CARPENTER TECHNOLOGY CORPORATION
  • 11.8. EVONIK INDUSTRIES AG
  • 11.9. BERKELEY ADVANCED BIOMATERAILS, INC.
  • 11.10. CAM BIOCERAMICS BV
  • 11.11. CELANESE CORPORATION

*Details might not be captured in case of unlisted companies

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.4. AVAILABLE CUSTOMIZATION
  • 12.5. RELATED REPORT
  • 12.6. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 2: GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 3: GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 4: GLOBAL STAINLESS STEEL BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: GLOBAL COBALT-CHROME ALLOY BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: GLOBAL GOLD BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: GLOBAL SILVER BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: GLOBAL MAGNESIUM BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: GLOBAL CERAMIC BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 11: GLOBAL CERAMIC BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 12: GLOBAL CALCIUM PHOSPHATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: GLOBAL ZIRCONIA BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: GLOBAL ALUMINUM OXIDE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: GLOBAL CALCIUM SULFATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL CARBON BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 17: GLOBAL GLASS BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 19: GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 20: GLOBAL POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL POLYETHYLENE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: GLOBAL POLYESTER BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: GLOBAL POLYVINYLCHLORIDE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: GLOBAL SILICONE RUBBER BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL NYLON BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: GLOBAL POLYETHERETHERKETONE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: GLOBAL POLYLACTIC ACID, POLY GLYCOLIC ACID, AND POLY(LACTIDE-CO-GLYCOLIDE) BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: GLOBAL OTHER POLYMERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: APPLICATIONS OF NATURAL BIOMATERIALS
  • TABLE 30: GLOBAL NATURAL BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 31: GLOBAL NATURAL BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 32: GLOBAL HYALURONIC ACID BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: GLOBAL COLLAGEN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: GLOBAL GELATIN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: GLOBAL FIBRIN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: GLOBAL CELLULOSE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: GLOBAL CHITIN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: GLOBAL ALGINATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: GLOBAL SILK BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 41: BIOMATERIALS MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 42: BIOMATERIALS MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 43: BIOMATERIALS MARKET SIZE FOR CATHETERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 44: BIOMATERIALS MARKET SIZE FOR STENTS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 45: BIOMATERIALS MARKET SIZE FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 46: BIOMATERIALS MARKET SIZE FOR PACEMAKERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 47: BIOMATERIALS MARKET SIZE FOR SENSORS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 48: BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
  • TABLE 49: BIOMATERIALS MARKET SIZE FOR HEART VALVES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 50: BIOMATERIALS MARKET SIZE FOR VASCULAR GRAFTS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 51: BIOMATERIALS MARKET SIZE FOR GUIDEWIRES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 52: BIOMATERIALS MARKET SIZE FOR OTHER CARDIOVASCULAR IMPLANTS/DEVICES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 53: BIOMATERIALS MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 54: BIOMATERIALS MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 55: JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION)
  • TABLE 56: JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 57: KNEE REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58: HIP REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 59: SHOULDER REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 60: OTHER JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: VISCOSUPPLEMENTATION BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 62: BIORESORBABLE BIOMATERIALS MARKET SIZE, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 63: BIORESORBABLE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 64: BIOMATERIALS MARKET SIZE FOR SUTURE ANCHORS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: BIOMATERIALS MARKET SIZE FOR INTERFERENCE SCREWS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 66: BIOMATERIALS MARKET SIZE FOR MENISCAL REPAIR TACKS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 67: BIOMATERIALS MARKET SIZE FOR MESHES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 68: SPINE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 69: SPINE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 70: SPINAL FUSION BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 71: BIOMATERIALS MARKET SIZE FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 72: BIOMATERIALS MARKET SIZE FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 73: BIOMATERIALS MARKET SIZE FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 74: BIOMATERIALS MARKET SIZE FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 75: BIOMATERIALS MARKET SIZE FOR INTERSPINOUS SPACERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 76: BIOMATERIALS MARKET SIZE FOR DISC ARTHROPLASTY/REPLACEMENT, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 77: BIOMATERIALS MARKET SIZE FOR FRACTURE FIXATION, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 78: BIOMATERIALS MARKET SIZE FOR BONE PLATES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 79: BIOMATERIALS MARKET SIZE FOR SCREWS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 80: BIOMATERIALS MARKET SIZE FOR PINS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 81: BIOMATERIALS MARKET SIZE FOR RODS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 82: BIOMATERIALS MARKET SIZE FOR WIRES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 83: SYNTHETIC BONE GRAFT BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 84: BIOMATERIALS MARKET SIZE FOR OPHTHALMOLOGY APPLICATIONS, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 85: OPHTHALMOLOGY BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 86: BIOMATERIALS MARKET SIZE FOR CONTACT LENSES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 87: BIOMATERIALS MARKET SIZE FOR INTRAOCULAR LENSES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 88: BIOMATERIALS MARKET SIZE FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 89: BIOMATERIALS MARKET SIZE FOR SYNTHETIC CORNEAS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 90: BIOMATERIALS MARKET SIZE FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 91: BIOMATERIALS MARKET SIZE FOR DENTAL APPLICATIONS, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 92: DENTAL BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 93: BIOMATERIALS MARKET SIZE FOR DENTAL IMPLANTS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 94: BIOMATERIALS MARKET SIZE FOR DENTAL BONE GRAFTS & GRAFT SUBSTITUTES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 95: BIOMATERIALS MARKET SIZE FOR DENTAL MEMBRANES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 96: BIOMATERIALS MARKET SIZE FOR TISSUE REGENERATION, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 97: BIOMATERIALS MARKET SIZE FOR PLASTIC SURGERY, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 98: BIOMATERIALS MARKET SIZE FOR PLASTIC SURGERY, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 99: BIOMATERIALS MARKET SIZE FOR SOFT TISSUE FILLERS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 100: BIOMATERIALS MARKET SIZE FOR CRANIOFACIAL SURGERY, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 101: BIOMATERIALS MARKET SIZE FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2014-2021 (USD BILLION)
  • TABLE 102: BIOMATERIALS MARKET SIZE FOR WOUND HEALING APPLICATIONS, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 103: BIOMATERIALS MARKET SIZE FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 104: BIOMATERIALS MARKET SIZE FOR WOUND CLOSURE DEVICES, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 105: BIOMATERIALS MARKET SIZE FOR SUTURES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 106: BIOMATERIALS MARKET SIZE FOR STAPLES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 107: BIOMATERIALS MARKET SIZE FOR SURGICAL HEMOSTATS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 108: BIOMATERIALS MARKET SIZE FOR INTERNAL TISSUE SEALANTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 109: BIOMATERIALS MARKET SIZE FOR ADHESION BARRIERS, BY REGION, 2014-2021(USD MILLION)
  • TABLE 110: BIOMATERIALS MARKET SIZE FOR HERNIA MESHES, BY REGION, 2014-2021(USD MILLION)
  • TABLE 111: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 112: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 113: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2014-2021(USD MILLION)
  • TABLE 114: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 115: TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 116: BIOMATERIALS MARKET SIZE FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2014-2021(USD MILLION)
  • TABLE 117: BIOMATERIALS MARKET SIZE FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 118: BIOMATERIALS MARKET SIZE FOR SHUNTING SYSTEMS, BY REGION, 2014-2021(USD MILLION)
  • TABLE 119: BIOMATERIALS MARKET SIZE FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 120: BIOMATERIALS MARKET SIZE FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 121: BIOMATERIALS MARKET SIZE FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2014-2021(USD MILLION)
  • TABLE 122: OTHER BIOMATERIAL APPLICATIONS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: OTHER BIOMATERIAL APPLICATIONS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 124: BIOMATERIALS MARKET SIZE FOR DRUG DELIVERY SYSTEMS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 125: BIOMATERIALS MARKET SIZE FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2014-2021(USD MILLION)
  • TABLE 126: BIOMATERIALS MARKET SIZE FOR BARIATRIC SURGERY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 127: BIOMATERIALS MARKET SIZE FOR URINARY APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 128: BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION)
  • TABLE 129: NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 130: NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 131: NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 132: CONFERENCES AND SYMPOSIUMS ON BIOMATERIALS IN THE U.S.
  • TABLE 133: U.S.: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 134: U.S.: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 135: CANADA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 136: CANADA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 137: EUROPE: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 138: EUROPE: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 139: EUROPE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 140: GERMANY: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 141: GERMANY: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 142: CONFERENCES AND SYMPOSIUMS ON BIOMATERIALS IN U.K.
  • TABLE 143: U.K.: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 144: U.K.: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 145: FRANCE: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 146: FRANCE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 147: SPAIN: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 148: SPAIN: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 149: GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL)
  • TABLE 150: ROE: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 151: ROE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 152: ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION)
  • TABLE 153: ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 154: ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION)
  • TABLE 155: JAPAN: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 156: JAPAN: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 157: CHINA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 158: CHINA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 159: INDIA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 160: INDIA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 161: ROAPAC: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION)
  • TABLE 162: ROAPAC: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 163: PERCENTAGE OF OBESE POPULATION IN LATIN AMERICAN COUNTRIES
  • TABLE 164: ROW: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION)
  • TABLE 165: ROW: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 166: AGREEMENTS , COLLABORATIONS, PATNERSHIPS, AND JOINT VENTURES BY COMPANIES (2013-2016)
  • TABLE 167: PRODUCT LAUNCHES BY COMPANIES (2013-2016)
  • TABLE 168: MERGER AND ACQUISITIONS BY COMPANIES (2013-2016)
  • TABLE 169: EXPANSIONS BY COMPANIES (2013-2016)
  • TABLE 170: OTHER STRATEGIES BY COMPANIES (2013-2016)

LIST OF FIGURES

  • FIGURE 1: GLOBAL BIOMATERIALS MARKET SEGMENTATION
  • FIGURE 2: RESEARCH METHODOLOGY: BIOMATERIALS MARKET
  • FIGURE 3: BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: POLYMERIC BIOMATERIALS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 8: TITANIUM & TITANIUM ALLOYS SEGMENT IN THE METALLIC BIOMATERIALS MARKET TO REGISTER THE HIGHEST CAGR
  • FIGURE 9: CALCIUM PHOSPHATE SEGMENT IN THE CERAMIC BIOMATERIALS MARKET TO GROW AT THE HIGHEST RATE
  • FIGURE 10: POLYMETHYLMETHACRYLATE SEGMENT TO DOMINATE THE POLYMERIC BIOMATERIALS MARKET IN 2016
  • FIGURE 11: HYALURONIC ACID SEGMENT IN THE NATURAL BIOMATERIALS MARKET TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 12: CARDIOVASCULAR SEGMENT TO FORM THE LARGEST APPLICATION SEGMENT IN THE BIOMATERIALS MARKET (2016)
  • FIGURE 13: ASIA-PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 14: TECHNOLOGICAL ADVANCEMENTS AND GROWTH IN NUMBER OF HIP AND KNEE REPLACEMENT PROCEDURES ARE KEY MARKET DRIVERS
  • FIGURE 15: PLASTIC SURGERY APPLICATION SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16: NORTH AMERICA TO DOMINATE THE BIOMATERIALS MARKET, BY TYPE
  • FIGURE 17: ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 18: BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: U.S.: REGULATORY APPROVAL PROCESS
  • FIGURE 20: REGULATORY APPROVAL TIMELINE IN THE U.S.
  • FIGURE 21: EUROPE: REGULATORY APPROVAL PROCESS
  • FIGURE 22: REGULATORY APPROVAL TIMELINE IN EUROPE
  • FIGURE 23: JAPAN: REGULATORY APPROVAL PROCESS
  • FIGURE 24: REGULATORY APPROVAL TIMELINE IN JAPAN
  • FIGURE 25: CHINA: REGULATORY APPROVAL PROCESS
  • FIGURE 26: REGULATORY APPROVAL TIMELINE IN CHINA
  • FIGURE 27: INDIA: REGULATORY APPROVAL PROCESS
  • FIGURE 28: REGULATORY APPROVAL TIMELINE IN INDIA
  • FIGURE 29: AUSTRALIA: REGULATORY APPROVAL PROCESS
  • FIGURE 30: REGULATORY APPROVAL TIMELINE IN AUSTRALIA
  • FIGURE 31: POLYMERIC BIOMATERIALS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 32: TITANIUM AND TITANIUM ALLOYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 33: GLOBAL CERAMIC BIOMATERIALS MARKET, BY TYPE, 2016 VS 2021
  • FIGURE 34: PMMA SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 35: HYALURONIC ACID SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 36: PLASTIC SURGERY SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 37: STENTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 38: JOINT REPLACEMENT TO DOMINATE THE ORTHOPEDIC BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 39: CONTACT LENSES SEGMENT TO DOMINATE THE OPHTHALMOLOGY BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 40: DENTAL IMPLANTS SEGMENT TO DOMINATE THE DENTAL BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 41: SOFT TISSUE FILLERS SEGMENT TO DOMINATE THE PLASTIC SURGERY BIOMATERIALS MARKET DURING THE FORECAST PERIOD
  • FIGURE 42: INTERNAL TISSUE SEALANTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 43: SCAFFOLDS FOR REGENERATIVE MEDICINE SEGMENT REGISTERS LARGEST MARKET SHARE IN 2016
  • FIGURE 44: CORTICAL NEURAL PROSTHETICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 45: DRUG DELIVERY SYSTEMS TO DOMINATE THE OTHER BIOMATERIAL APPLICATIONS MARKET DURING THE FORECAST PERIOD
  • FIGURE 46: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL BIOMATERIALS MARKET IN 2016
  • FIGURE 47: NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 48: EUROPE: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 49: ASIA-PACIFIC: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 50: ROW: BIOMATERIALS MARKET SNAPSHOT
  • FIGURE 51: KEY GROWTH STRATEGIES, ADOPTED BY MARKET PLAYERS
  • FIGURE 52: AGREEMENTS, COLLABORATIONS, PATNERSHIPS, AND JOINT VENTURES BY COMPANIES (2013-2016)
  • FIGURE 53: PRODUCT LAUNCHES BY COMPANIES (2013-2016)
  • FIGURE 54: MERGERS AND ACQUISITIONS BY COMPANIES (2013-2016)
  • FIGURE 55: EXPANSIONS BY COMPANIES (2013-2016)
  • FIGURE 56: OTHER STRATEGIES BY COMPANIES (2013-2016)
  • FIGURE 57: PRODUCTS OFFERED BY COMPANIES IN THE BIOMATERIALS MARKET 218  
  • FIGURE 58: COMPANY SNAPSHOT: ROYAL DSM
  • FIGURE 59: COMPANY SNAPSHOT: BASF SE
  • FIGURE 60: COMPANY SNAPSHOT: CORBION N.V
  • FIGURE 61: COMPANY SNAPSHOT: BAYER AG
  • FIGURE 62: COMPANY SNAPSHOT: COVESTRO
  • FIGURE 63: COMPANY SNAPSHOT: VICTREX PLC
  • FIGURE 64: COMPANY SNAPSHOT: CARPENTER TECHNOLOGY CORPORATION
  • FIGURE 65: COMPANY SNAPSHOT: EVONIK INDUSTRIES AG
  • FIGURE 66: COMPANY SNAPSHOT: CELANESE CORPORATION
Back to Top